Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hajifathali, Abbas  [Clear All Filters]
2024
Kadkhoda D, Nikoonezhad M, Bonakchi H, Mehdizadeh M, Hajifathali A, Baghestani AReza, Jabarinanva L, Maboudi AAkbar Khad. Investigating the effect of pre-transplant thrombocytopenia and anemia on the engraftment and long-term survival in multiple myeloma patients. Transpl Immunol. 2024:101991.
2023
Bakhtiyaridovvombaygi M, Yazdanparast S, Mikanik F, Izadpanah A, Parkhideh S, Ghasabeh AShahbaz, Roshandel E, Hajifathali A, Gharehbaghian A. Cytokine-Induced Memory-Like NK Cells: Emerging strategy for AML immunotherapy. Biomed Pharmacother. 2023;168:115718.
Firouzi J, Hajifathali A, Azimi M, Parvini N, Ghaemi F, Asl NShayan, Asl AAbbas Heda, Safa M, Ebrahimi M. Hsp70, in Combination with IL-15 and PD-1 Blocker, Interferes with The Induction of Cytotoxic NK Cells in Relapsed Acute Myeloid Leukemia Patients. Cell J. 2023;25(2):92-101.
Mehdizadeh M, Tehrani HAzhdari, Rezvani H, Zamani S, Salari S, Hajifathali A. Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Ther. 2023;6(3):87-94.
Rafiee M, Amiri F, Mohammadi MHossein, Hajifathali A. MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation. BMC Cancer. 2023;23(1):202.
Hajifathali A, Lasemi MVahdat, Mehravar M, Moshari MReza, Alizadeh AMohammad, Roshandel E. Novelty in improvement of CAR T cell-based immunotherapy with the aid of CRISPR system. Hematol Transfus Cell Ther. 2023.
Mohamadifard Z, Fathi-Ashtian A, Hajifathali A, Nasrollahi B, Ahmadi F. Survival protection of patients undergoing hematopoietic stem cell transplantation: grounded theory. Support Care Cancer. 2023;31(7):381.
Jalili A, Hajifathali A, Mohammadian M, Sankanian G, Sayahinouri M, Ghorbi MDehghani, Roshandel E, Aghdami N. Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation. Adv Pharm Bull. 2023;13(3):469-482.
2022
Hosseinzadeh F, Ai J, Hajifathali A, Muhammadnejad S, Ebrahimi-Barough S, Seyhoun I, Movahed TKomeili, Shirian S, Hosseinzadeh F, Ahmadpour S, et al. The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach. Pharmacol Rep. 2022.
Mirfakhraie R, Ardakani MTavakoli, Hajifathali A, Karami S, Moshari MReza, Hasani M, Firouz SMashayekhi, Roshandel E. Highlighting the interaction between immunomodulatory properties of mesenchymal stem cells and signaling pathways contribute to Graft Versus Host Disease management. Transpl Immunol. 2022:101524.
Roshandel E, Ghaffari-Nazari H, Mohammadian M, Salimi M, Abroun S, Mirfakhraie R, Hajifathali A. NK cell therapy in relapsed refractory multiple myeloma. Clin Immunol. 2022;246:109168.
2021
Ghalesardi OKiani, Khosravi A, Azizi E, Ahmadi SEsmaeil, Hajifathali A, Bonakchi H, Shahidi M. The prognostic importance of BCR-ABL transcripts in Chronic Myeloid Leukemia: A systematic review and meta-analysis. Leuk Res. 2021;101:106512.
Mirfakhraie R, Noorazar L, Mohammadian M, Hajifathali A, Gholizadeh M, Salimi M, Sankanian G, Roshandel E, Mehdizadeh M. Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles. Leuk Res. 2021;112:106751.
2020
Mehravar M, Roshandel E, Salimi M, Chegeni R, Gholizadeh M, Mohammadi MHossein, Hajifathali A. Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies. Immunol Lett. 2020.
2019
Salehnasab C, Hajifathali A, Asadi F, Roshandel E, Kazemi A, Roshanpoor A. Machine Learning Classification Algorithms to Predict aGvHD following Allo-HSCT: A Systematic Review. Methods Inf Med. 2019;58(6):205-212.
2014
Hajifathali A, Saba F, Atashi A, Soleimani M, Mortaz E, Rasekhi M. The role of catecholamines in mesenchymal stem cell fate. Cell Tissue Res. 2014.
2013
Habibi H, Abroun S, Hajifathali A, Soleimani M, Kaviani S, Kalantari N, Eslahchi S. Osteogenic inhibition in multiple myeloma. Cell J. 2013;15(3):266-71.
Mehdizadeh M, Hajifathali A, Tabarraee M, Tavakoli-Ardakani M. Plerixafor in the treatment of stem cell mobilization failure; first experience in iran. Iran J Pharm Res. 2013;12(Suppl):189-91.